Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP566509.RAUNqD0crGctfK3z855KmRHQ2BubSHI0PSIuCQpPpKRKE130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP566509.RAUNqD0crGctfK3z855KmRHQ2BubSHI0PSIuCQpPpKRKE130_provenance.
• NP486119.RACaw_J_SXa-8DzeBosSLAeV8caUWX2QiG2rfPX_8g8xQ130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP486119.RACaw_J_SXa-8DzeBosSLAeV8caUWX2QiG2rfPX_8g8xQ130_provenance.
• NP522226.RAhOcZ0RkMV-AhlyAGajDbmD9eedDAJ7Iv6ZSW0TwZLMI130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP522226.RAhOcZ0RkMV-AhlyAGajDbmD9eedDAJ7Iv6ZSW0TwZLMI130_provenance.
• NP379050.RAhRyhIpIVusfBiGHbSs22FoWva456MFhMb8B7EGg_kmM130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379050.RAhRyhIpIVusfBiGHbSs22FoWva456MFhMb8B7EGg_kmM130_provenance.
• NP652927.RApT5gZENwuJsKmsm-LJsNec_qfc4faHn1mb6wHRugV0w130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP652927.RApT5gZENwuJsKmsm-LJsNec_qfc4faHn1mb6wHRugV0w130_provenance.
• NP868694.RAQgrONNAg2qO873eAs1l8GcIbxOq9-ePRb1O3-Vr4uXA130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP868694.RAQgrONNAg2qO873eAs1l8GcIbxOq9-ePRb1O3-Vr4uXA130_provenance.
• NP417514.RALMFrr1E765hHJlc-HE36wHQeHLA7Pn7SiecwgnUHeiE130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP417514.RALMFrr1E765hHJlc-HE36wHQeHLA7Pn7SiecwgnUHeiE130_provenance.
• NP625182.RAWg36QieFDmI_2QBcQ5wk_BPyXhktnytNrUYvAwdbxTs130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625182.RAWg36QieFDmI_2QBcQ5wk_BPyXhktnytNrUYvAwdbxTs130_provenance.
• NP625703.RAc2e7dsjkqMuHWH2M5LvZIBkhAaTp-RyNpXyHKJTD6SA130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625703.RAc2e7dsjkqMuHWH2M5LvZIBkhAaTp-RyNpXyHKJTD6SA130_provenance.
• NP761861.RAyc6_VEUvC7JM6ByWV_hZNvF81o9Fd9I0YMgOGnrEq_o130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761861.RAyc6_VEUvC7JM6ByWV_hZNvF81o9Fd9I0YMgOGnrEq_o130_provenance.
• NP894771.RA-r8o_2IsntYHxfvWd7YG2U63n3OPDTeO0iIvyCZGZJw130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP894771.RA-r8o_2IsntYHxfvWd7YG2U63n3OPDTeO0iIvyCZGZJw130_provenance.
• assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1111368.RAb-12VEZGkfpdZrI_yWJgNqCN5Ab7n22RBKxVHbyJ0nk130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1111368.RAb-12VEZGkfpdZrI_yWJgNqCN5Ab7n22RBKxVHbyJ0nk130_provenance.
• NP1111370.RAVF2o1vbVIlEsl-mvYcoBdXlY1bDMHPfollV_aJ0yKsI130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1111370.RAVF2o1vbVIlEsl-mvYcoBdXlY1bDMHPfollV_aJ0yKsI130_provenance.
• NP1111371.RAUENyp7Z84VMzy_6rFAr1aCvlqLzxktROUjdPgqrVMMs130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1111371.RAUENyp7Z84VMzy_6rFAr1aCvlqLzxktROUjdPgqrVMMs130_provenance.
• NP786223.RAFhjxyjKx6Cx63u8tSqC1nz9HTC9sKoOE0P2KE63V3xw130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP786223.RAFhjxyjKx6Cx63u8tSqC1nz9HTC9sKoOE0P2KE63V3xw130_provenance.
• NP622726.RAh7N5iF6iqz4VuOa8n1u0JnkiI7PKEC83wy7v9Bbrwok130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622726.RAh7N5iF6iqz4VuOa8n1u0JnkiI7PKEC83wy7v9Bbrwok130_provenance.
• NP625249.RAvC1HPTGx6WpcFSlzHGKRICJMJka_OyfX2YH1D8ld6yc130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625249.RAvC1HPTGx6WpcFSlzHGKRICJMJka_OyfX2YH1D8ld6yc130_provenance.
• NP1111367.RAjWa61CcawWuZAM4EXokVm9Mx-LQ9zvxPvy1_PndILAI130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1111367.RAjWa61CcawWuZAM4EXokVm9Mx-LQ9zvxPvy1_PndILAI130_provenance.
• NP1111372.RAm92eCvMI2xv3gcsnO4YUEAHZwRz68V-ejm2DbhAZ2sU130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1111372.RAm92eCvMI2xv3gcsnO4YUEAHZwRz68V-ejm2DbhAZ2sU130_provenance.
• NP1111374.RAqZI2I-xgE8aWeOcRXmWtsgy7k38uc4BIZTDb2t7jgRA130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1111374.RAqZI2I-xgE8aWeOcRXmWtsgy7k38uc4BIZTDb2t7jgRA130_provenance.
• NP621374.RAFWhG32jWTM9sEEi49jIcu7NZwMC-GZa1yJnqzePTTqs130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621374.RAFWhG32jWTM9sEEi49jIcu7NZwMC-GZa1yJnqzePTTqs130_provenance.
• NP624042.RAKpZvytTR_iq2jC2txyI36k0LlgLULhqLKHv3V3VL4Gs130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624042.RAKpZvytTR_iq2jC2txyI36k0LlgLULhqLKHv3V3VL4Gs130_provenance.
• NP624559.RAOdxDcQOv6lbddTwbouCCDJE12FLYRhBXODSXZo42uao130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624559.RAOdxDcQOv6lbddTwbouCCDJE12FLYRhBXODSXZo42uao130_provenance.
• NP621477.RA2GQ7-XWsycr2JP-v8t7ujDpvuigVOJd6GpYdN3jn4fQ130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621477.RA2GQ7-XWsycr2JP-v8t7ujDpvuigVOJd6GpYdN3jn4fQ130_provenance.
• NP622110.RAxTRbXqP-PAIiDjMzoMaFf2zoSu9jLSNeccfWNg4a1F0130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622110.RAxTRbXqP-PAIiDjMzoMaFf2zoSu9jLSNeccfWNg4a1F0130_provenance.
• NP622792.RA5ts0Ga-R5Ye5fhbCc4cn7MDne6vBpWvMjFumi3VDkQc130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622792.RA5ts0Ga-R5Ye5fhbCc4cn7MDne6vBpWvMjFumi3VDkQc130_provenance.
• NP623243.RA8KqIrznSf3_jRmkI_NN8wjm8qbL_U_n26wIZye4oHuA130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623243.RA8KqIrznSf3_jRmkI_NN8wjm8qbL_U_n26wIZye4oHuA130_provenance.
• NP624108.RAyRfHeuVoJPOy7eP4p2OEwskdZv8Jco3E3VrdouL0SFU130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624108.RAyRfHeuVoJPOy7eP4p2OEwskdZv8Jco3E3VrdouL0SFU130_provenance.
• NP1111362.RAEAYXZENcbGyTZVEgemA4RbSjJ1FmR_41WAWiaWjwdd4130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1111362.RAEAYXZENcbGyTZVEgemA4RbSjJ1FmR_41WAWiaWjwdd4130_provenance.
• NP1111364.RALdAk9pV5AutD9AIL1Q_P0Gkt3o4C31aD9NDj5mTF7_M130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1111364.RALdAk9pV5AutD9AIL1Q_P0Gkt3o4C31aD9NDj5mTF7_M130_provenance.
• NP1111365.RAHxtEcSxdplwm-NEWqTuQqwKLh89gPFyNWwgrn6sRxEs130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1111365.RAHxtEcSxdplwm-NEWqTuQqwKLh89gPFyNWwgrn6sRxEs130_provenance.
• NP1111373.RAFAxsUN8XgzJZW3DON87Og1ENtvu86gxGCIF8mi_bJEo130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1111373.RAFAxsUN8XgzJZW3DON87Og1ENtvu86gxGCIF8mi_bJEo130_provenance.
• NP1111363.RA5BOhpS7BFxS-3zSgwOvZWJfRpMVl9UIJKp7yosmGQpQ130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1111363.RA5BOhpS7BFxS-3zSgwOvZWJfRpMVl9UIJKp7yosmGQpQ130_provenance.
• NP1111366.RA_X3_0EhLk_47UhwUtrajBFaRHiIx_jVHauTDGNWFYvo130_assertion description "[Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1111366.RA_X3_0EhLk_47UhwUtrajBFaRHiIx_jVHauTDGNWFYvo130_provenance.